Brief: Aap Implantate now sees FY EBITDA of 18.1 - 19.7 million euros
10/08/2016 08:42
Aug 10 (Reuters) - Aap Implantate AG AAQG.DE :
* Deconsolidation profit from the sale of Aap Biomaterials
GmbH leads to an increase of 2016 EBITDA forecast for the group
* Sees FY 2016 EBITDA of group of between 18.1 million and
19.7 million euros (previously between 14.1 million and 15.7
million euros)
* Now sees FY EBITDA of continued operation of between -5.9
million and -4.3 million euros
Source text for Eikon: ID:nEQS0jcba
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co